ID   Amsalem
AC   CVCL_B386
DR   ATCC; CRL-2628
DR   Wikidata; Q54749842
RX   PubMed=2981779;
RX   PubMed=6181032;
CC   Doubling time: 36-48 hours (PubMed=2981779).
CC   Discontinued: ATCC; CRL-2628; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=2981779; DOI=10.1002/ijc.2910350106;
RA   Ben-Bassat H., Rabinowitz R., Polliack A., Hadar R., Schlesinger M.;
RT   "Establishment of the Amsalem T-cell line from a patient with acute
RT   lymphoblastic leukemia. Expression of E-receptor-associated antigens
RT   in cells incapable of forming E-rosettes.";
RL   Int. J. Cancer 35:27-33(1985).
//
RX   PubMed=6181032; DOI=10.1016/0198-8859(82)90037-4;
RA   Rabinowitz R., Weinstock J., Margalioth E.J., Ben-Bassat H.,
RA   Schlesinger M.;
RT   "Antigens specific for human T-lymphocytes detected by xenoantisera to
RT   HD-MAR cells: their differential expression on various T-cell lines.";
RL   Hum. Immunol. 4:219-228(1982).
//